Little Things Make Big Things Happen
- 1 June 2015
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 143 (6) , 889-894
Abstract
Objectives: Size, invasion of thoracic structures, and ipsilateral mediastinal lymph node involvement (pN2) are well-known prognostic factors that configure the staging of resectable, locally advanced non–small cell lung cancer (LA-NSCLC). The prognostic impact of angiolymphatic invasion (ALI) and tumor necrosis (TN) has been barely explored in LA-NSCLC treated with prior induction therapies. Methods: We retrospectively reviewed 47 resected LA-NSCLCs treated with a prior platin-based chemotherapy or chemoradiation. The impact of ALI, TN, and other pathologic features on survival was analyzed. Results: ALI was presented in 23.4% of cases and TN in 29.8%. Disease-free and overall survival decreased when ALI, TN, or pN2 was present. The incidence of ALI was lower in LA-NSCLC with a good response to induction. Conclusion: Our series is the first to report the prognostic impact of ALI and TN in induction-treated LA-NSCLC. The presence of ALI and TN should be included in the pathologic reports.Keywords
This publication has 38 references indexed in Scilit:
- Characteristics and Prognostic Value of Lymphatic and Blood Vascular Microinvasion in Lung CancerThe Annals of Thoracic Surgery, 2012
- The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction ChemotherapyThe Annals of Thoracic Surgery, 2012
- Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized TrialsJournal of Thoracic Oncology, 2012
- Persistent N2 disease after neoadjuvant chemotherapy for non–small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2011
- Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataThe Lancet, 2010
- The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of PneumonectomyThe Annals of Thoracic Surgery, 2008
- The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLCLung Cancer, 2008